Published in Vaccine on August 22, 2011
The Value Adults Place on Child Health and Functional Status. Value Health (2015) 0.82
Prevalence and Losses in Quality-Adjusted Life Years of Child Health Conditions: A Burden of Disease Analysis. Matern Child Health J (2016) 0.77
Valuation of Child Behavioral Problems from the Perspective of US Adults. Med Decis Making (2015) 0.77
The use of the EQ-5D-Y health related quality of life outcome measure in children in the Western Cape, South Africa: psychometric properties, feasibility and usefulness - a longitudinal, analytical study. Health Qual Life Outcomes (2017) 0.75
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health (2011) 5.12
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health (2011) 3.88
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A (2011) 3.51
Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. Value Health (2011) 2.88
Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res (2002) 2.36
Conjoint Analysis Applications in Health - How are Studies being Designed and Reported?: An Update on Current Practice in the Published Literature between 2005 and 2008. Patient (2010) 2.30
H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. PLoS One (2011) 2.02
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep (2014) 1.97
Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health (2007) 1.86
Measuring what people value: a comparison of "attitude" and "preference" surveys. Health Serv Res (2002) 1.75
Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine. Clin Infect Dis (2004) 1.52
Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysis. Lung Cancer (2012) 1.44
Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Pediatrics (2006) 1.38
A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Pediatrics (2005) 1.34
Cholesterol reduction yields clinical benefits: meta-analysis including recent trials. Clin Ther (2007) 1.34
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial. J Infect Dis (2008) 1.28
How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ (2009) 1.27
Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). Int J Infect Dis (2007) 1.19
The HPV vaccine: are dosing recommendations being followed? Vaccine (2011) 1.18
RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe. Vaccine (2009) 1.16
How does cost matter in health-care discrete-choice experiments? Health Econ (2011) 1.15
Burden of childhood rotavirus disease on health systems in the United States. Pediatr Infect Dis J (2010) 1.13
Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation. Diabetes Care (2003) 1.12
Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. Vaccine (2009) 1.09
Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009. Vaccine (2012) 1.09
Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinoma. J Med Econ (2012) 1.08
Patient preferences for surgical versus medical therapy for ulcerative colitis. Inflamm Bowel Dis (2014) 1.05
Risking health to avoid injections: preferences of Canadians with type 2 diabetes. Diabetes Care (2005) 1.04
The impact of rotavirus gastroenteritis on the family. BMC Pediatr (2009) 1.03
Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. J Antimicrob Chemother (2006) 1.00
Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment. Qual Life Res (2006) 0.96
Benefits, risk, and uncertainty: preferences of antiretroviral-naïve African Americans for HIV treatments. AIDS Patient Care STDS (2009) 0.96
Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico. BMC Infect Dis (2008) 0.96
Hypothetical bias, cheap talk, and stated willingness to pay for health care. J Health Econ (2009) 0.94
Estimating older adults' preferences for walking programs via conjoint analysis. Am J Prev Med (2009) 0.94
The effectiveness of a primary care-based pediatric obesity program. Clin Pediatr (Phila) (2011) 0.91
Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario. Vaccine (2013) 0.89
Patient preferences for treatments to delay bone metastases. Prostate (2014) 0.89
Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom. Support Care Cancer (2014) 0.88
2009 H1N1 and seasonal influenza immunization among pregnant women: a comparison of different sources of immunization information. Matern Child Health J (2014) 0.87
Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data. Patient (2013) 0.87
Editorial: Moving the QALY forward or just stuck in traffic? Value Health (2009) 0.86
Parents' reported preference scores for childhood atopic dermatitis disease states. BMC Pediatr (2004) 0.86
How do physicians weigh benefits and risks associated with treatments in patients with osteoarthritis in the United Kingdom? J Rheumatol (2012) 0.85
Patients' benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapies. Ann Pharmacother (2010) 0.85
Einstein on willingness to pay per QALY: is there a better way? Med Decis Making (2005) 0.85
Patients' willingness to trade off between the duration and frequency of rheumatoid arthritis treatments. Arthritis Care Res (Hoboken) (2014) 0.84
Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medications. Allergy Asthma Proc (2009) 0.84
Eliciting benefit-risk preferences and probability-weighted utility using choice-format conjoint analysis. Med Decis Making (2011) 0.84
Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndrome. Value Health (2009) 0.83
Burden of rotavirus hospitalisations in young children in three paediatric hospitals in the United States determined by active surveillance compared to standard indirect methods. J Paediatr Child Health (2012) 0.83
Economic evaluation of the benefits of reducing acute cardiorespiratory morbidity associated with air pollution. Environ Health (2002) 0.83
Physician preferences for extra-glycemic effects of type 2 diabetes treatments. Diabetes Ther (2013) 0.82
Patients' willingness to accept the risks and benefits of new treatments for chronic hepatitis C virus infection. Patient (2012) 0.79
Who pays attention in stated-choice surveys? Health Econ (2010) 0.79
Estimating importance weights for the IWQOL-Lite using conjoint analysis. Qual Life Res (2010) 0.79
Understanding the relative importance of preserving functional abilities in Alzheimer's disease in the United States and Germany. Qual Life Res (2014) 0.78
Patient preferences and linear scoring rules for patient-reported outcomes. Patient (2010) 0.78
Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan. J Med Econ (2011) 0.77
Psychiatrists' judgments about antipsychotic benefit and risk outcomes and formulation in schizophrenia treatment. Psychiatr Serv (2014) 0.77
Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy. Eur J Gastroenterol Hepatol (2012) 0.77
Adolescent girls' preferences for HPV vaccines: a discrete choice experiment. Adv Health Econ Health Serv Res (2014) 0.77
Caregiver Preferences for the Treatment of Males with Fragile X Syndrome. J Dev Behav Pediatr (2016) 0.76
Older Americans' risk-benefit preferences for modifying the course of Alzheimer disease. Alzheimer Dis Assoc Disord (2009) 0.76
Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children. Pediatr Infect Dis J (2014) 0.75
Modeling for health care and other policy decisions: uses, roles, and validity. Value Health (2002) 0.75
Projected coronary heart disease risk benefit with ezetimibe. Atherosclerosis (2004) 0.75
National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom. Int J Cardiol (2003) 0.75
Evaluating migraineurs' preferences for migraine treatment outcomes using a choice experiment. Headache (2013) 0.75
Evaluation of the relative importance of chemotherapeutic and antiemetic efficacy in various oncologic settings. Support Care Cancer (2008) 0.75